Drug Safety Consulting & Pharmacovigilance Services
Because patient safety deserves expert focusExpert Medical Safety & Pharmacovigilance Support Across the Product Lifecycle
When drug safety expertise is critical and in-house capacity is limited, DES Pharma serves as a trusted extension of your team, bringing the leadership, scale, and judgment needed to move programs forward with confidence. Our drug safety consulting and pharmacovigilance services span signal detection, risk management, aggregate safety reporting, and inspection-ready case management, from first-in-human trials through post-marketing surveillance.
Phase 1/2:
Proactive signal detection, risk characterization, risk mitigation strategies, and communication.
- Establish medical safety strategies
- Regulatory safety strategies
- Safety portions of the target product profiles, study protocols, IBs, dose justifications
- Proactive safety monitoring and communication
- Drug monitoring committees
- Signal detection, risk mitigation strategies and implementation
- Aggregate reports
- Product profile for expanded indications
- Risk characterization, mitigation strategies, and implementation
- Marketing authorization application submissions
- QPPV
- Epidemiology
Phase 3/Post-Authorization
We drive Phase III and post-approval safety oversight that de-risks development, satisfies regulators, and protects patients.
- Continuous risk characterization, mitigation strategies, and implementation
- Independent drug monitoring committees
- RMPs, CCDSs, prescribing labels
Pharmacovigilance
We drive global, inspection-ready safety across the products’ lifecycle—combining compliant case management, blinded oversight, strong governance, and rapid regulatory response to de-risk development and enable your science to scale with growth.
- Pharmacovigilance Agreements
- Case processing, reporting, and oversight
- Quality and training
- KPIs
- Blinding processes for case processing and reporting, and oversight
- PSMF
- Expand capabilities for large-scale Phase 3 studies
Our teams combine strategic insight with hands-on execution to deliver medical safety solutions that support confident decision-making, regulatory success, and sustainable product growth.
What Is Drug Safety Consulting?
Drug safety consulting, also called pharmacovigilance consulting, is the specialized
support that helps pharmaceutical and biotech companies detect, assess, and prevent adverse effects of their products across the development lifecycle. It covers safety strategy, signal detection, risk mitigation, aggregate safety reporting, and regulatory-compliant case management. Companies engage drug safety consultants when in-house capacity is limited, when preparing for regulatory submissions, or when scaling pharmacovigilance operations for large Phase 3 and post-marketing programs.
DES Pharma provides drug safety consulting across three areas: Phase 1/2 safety strategy, Phase 3 and post-authorization safety oversight, and full-lifecycle pharmacovigilance operations.
Connect With Our Team TodayAdvance Your Drug Program
with Confidence
Start building reliable, high-quality drug development programs today.